Defective proviruses rapidly accumulate during acute HIV-1 infection

Cited by (745)

Items 301–400 of 745

1. Early Emergence and Long-Term Persistence of HIV-Infected T-Cell Clones in Children
   Michael J. Bale, Mary Grace Katusiime, Daria Wells, Xiaolin Wu, Jonathan Spindler, Elias Konstantine Halvas, Joshua C. Cyktor, Ann P. Wiegand, Wei Shao, Mark Fredric Cotton et al. · 2021 · mBio
2. HIV-1 integration sites in CD4+ T cells during primary, chronic, and late presentation of HIV-1 infection
   Yik Lim Kok, Valentina Vongrad, Sandra E Chaudron, Mohaned Shilaih, Christine Leemann, Kathrin Neumann, Katharina Kusejko, Francesca Di Giallonardo, Herbert Kuster, Dominique L. Braun et al. · 2021 · JCI Insight
3. Addressing an HIV cure in LMIC
   Sherazaan D. Ismail, Joshua Pankrac, Emmanuel Ndashimye, Jessica L. Prodger, Melissa-Rose Abrahams, Jamie F. S. Mann, Andrew D. Redd, Eric J. Arts · 2021 · Retrovirology
4. Chemistry and Bioinformatics Considerations in Using Next-Generation Sequencing Technologies to Inferring HIV Proviral DNA Genome-Intactness
   Guinevere Q. Lee · 2021 · Viruses
5. HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
   F. Harrison Omondi, Hanwei Sudderuddin, Aniqa Shahid, Natalie N. Kinloch, Bradley R. Jones, Rachel L. Miller, Olivia Tsai, Daniel MacMillan, Alicja Piechocka‐Trocha, Mark A. Brockman et al. · 2021 · mBio
6. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time
   Aniqa Shahid, Signe MacLennan, Bradley R. Jones, Hanwei Sudderuddin, Zhong Dang, Kyle D. Cobarrubias, Maggie C. Duncan, Natalie N. Kinloch, Michael J. Dapp, Nancie M. Archin et al. · 2024 · Journal of Virology
7. HIV-1-DNA/RNA and immunometabolism in monocytes: contribution to the chronic immune activation and inflammation in people with HIV-1
   Esperanza Muñoz‐Muela, María Trujillo‐Rodríguez, Ana Serna‐Gallego et al. · 2024 · EBioMedicine
8. Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue
   Eli Boritz, Daniel C. Douek · 2017 · The Journal of Infectious Diseases
9. Transplantation of CCR5∆32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
   Meghan K. Rothenberger, John E. Wagner, Ashley T. Haase et al. · 2018 · Open Forum Infectious Diseases
10. Brief Report: HIV Antibodies Decline During Antiretroviral Therapy but Remain Correlated With HIV DNA and HIV-Specific T-Cell Responses
    Sheila Marie Keating, Richard Brad Jones, Christina M. Lalama, Ronald J. Bosch, Deborah K. McMahon, Dylan Hampton, Joshua C. Cyktor, Joseph J. Eron, John W. Mellors, Michael Paul Busch et al. · 2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes
11. CRISPR/Cas9 and Genome Editing for Viral Disease—Is Resistance Futile?
    Harshana S. De Silva Feelixge, Daniel Stone, Pavitra Roychoudhury, Martine Aubert, Keith R. Jerome · 2018 · ACS Infectious Diseases
12. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy
    Roland Schwarzer, Andrea Gramatica, Warner C. Greene · 2020 · Viruses
13. Intact proviruses are enriched in the colon and associated with PD-1(+)TIGIT(-) mucosal CD4(+) T cells of people with HIV-1 on antiretroviral therapy
    Vellas, Camille, Nayrac, Manon, Collercandy, Nived, Requena, Mary, Jeanne, Nicolas, Latour, Justine, Dimeglio, Chloé, Cazabat, Michelle, Barange, Karl, Alric, Laurent et al. · 2024 · eBioMedicine
14. HIV reservoirs are dominated by genetically younger and clonally enriched proviruses
    Kinloch, Natalie N., Shahid, Aniqa, Dong, Winnie, Kirkby, Don, Jones, Bradley R., Beelen, Charlotte J., MacMillan, Daniel, Lee, Guinevere Q., Mota, Talia M., Sudderuddin, Hanwei et al. · 2023 · mBio
15. APOBEC3 family proteins as drivers of virus evolution
    Michael Jonathan, Terumasa Ikeda · 2023 · Frontiers in Virology
16. Genetic complexity in the replication-competent latent HIV reservoir increases with untreated infection duration in infected youth
    Zabrina L. Brumme, Hanwei Sudderuddin, Carrie Ziemniak · 2018 · AIDS
17. Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy
    Yanina Ghiglione, María L. Polo, Alejandra Urioste, Ajantha Rhodes, Alejandro Czernikier, César Trifone, María Florencia Quiroga, Alicia E Sisto, Patricia Patterson, Horacio Salomón et al. · 2020 · Open Forum Infectious Diseases
18. Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus
    Julie Janssens, Anne Bruggemans, Frauke Christ, Zeger Debyser · 2021 · Frontiers in Microbiology
19. Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda
    Samira Joussef-Piña, Immaculate Nankya, Sophie Nalukwago, Joy Baseke, Sandra Rwambuya, Dane Winner, Fred Kyeyune, Keith A. Chervenak, Bonnie Thiel, Robert J. Asaad et al. · 2022 · Retrovirology
20. Impact of Cannabis Use on Immune Cell Populations and the Viral Reservoir in People With HIV on Suppressive Antiretroviral Therapy
    Shane D. Falcinelli, Alicia D. Volkheimer, Lesia Semenova, Ethan Wu, Alexander Richardson, Manickam Ashokkumar, David M. Margolis, Nancie M. Archin, Cynthia D Rudin, David M. Murdoch et al. · 2023 · The Journal of Infectious Diseases
21. Estimating Initial Viral Levels during Simian Immunodeficiency Virus/Human Immunodeficiency Virus Reactivation from Latency
    Mykola Pinkevych, Christine M. Fennessey, Deborah Cromer · 2017 · Journal of Virology
22. A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice
    Harry D. J. Knights · 2017 · AIDS Research and Treatment
23. Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV
    Roberta Campagna, Chiara Nonne, Guido Antonelli, Ombretta Turriziani · 2024 · Viruses
24. Immunotherapeutic approaches to HIV cure and remission
    Ming Jie Lee, Sarah J. Fidler, John Frater · 2021 · Current Opinion in Infectious Diseases
25. In-Depth Characterization of Full-Length Archived Viral Genomes after Nine Years of Posttreatment HIV Control
    Pauline Trémeaux, Frédéric Lemoine, Adeline Mélard, Marine Gousset, Faroudy Boufassa, Sylvie Orr, Valérie Monceaux, Olivier Gascuel, Olivier Lambotte, Laurent Hocqueloux et al. · 2023 · Microbiology Spectrum
26. Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA
    Carolin Tumpach, Ajantha Rhodes, Youry Kim, Jesslyn Ong, Haoming Liu, Doris Chibo, Julian D Druce, Deborah Anne Williamson, Rebecca Hoh, Steven G. Deeks et al. · 2023 · Viruses
27. CD4+ T cells with latent HIV-1 have reduced proliferative responses to T cell receptor stimulation
    Joshua T. Kufera, Ciara Armstrong, Fengting Wu, Anushka Singhal, Hao Zhang, Jun Lai, Hannah N. Wilkins, Francesco Roberto Simonetti, Janet D'Angelo Siliciano, Robert F. Siliciano · 2024 · The Journal of Experimental Medicine
28. HIV-1 reservoir dynamics in CD4+ T cells
    Katherine M. Bruner, Lillian B. Cohn · 2018 · Current Opinion in HIV and AIDS
29. Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance
    Eleonora Olivetta, Chiara Chiozzini, Claudia Arenaccio, Francesco Manfredi, Flavia Ferrantelli, Maurizio Federico · 2019 · Cytokine & Growth Factor Reviews
30. Cohort profile: the Netherlands Cohort Study on Acute HIV infection (NOVA), a prospective cohort study of people with acute or early HIV infection who immediately initiate HIV treatment
    Maartje Dijkstra, Henrieke A. B. Prins, Jan M. Prins · 2021 · BMJ Open
31. A targeted reactivation of latent HIV-1 using an activator vector in patient samples from acute infection
    Jamie F. S. Mann, Joshua Pankrac, Katja Klein, Paul F. McKay, Deborah F. L. King, Richard M. Gibson, Chanuka N. Wijewardhana, Rahul Pawa, Jodi Meyerowitz, Yong Gao et al. · 2020 · EBioMedicine
32. Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places
    Wenxuan Chen, Ben Berkhout, Alexander O. Pasternak · 2025 · Current HIV/AIDS Reports
33. Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART
    Kelsie Brooks, F. Harrison Omondi, Richard H. Liang, Hanwei Sudderuddin, Bradley R. Jones, Jeffrey B. Joy, Chanson J. Brumme, Eric Hunter, Zabrina L. Brumme · 2021 · Frontiers in Microbiology
34. Viral and Host Biomarkers of HIV Remission Post Treatment Interruption
    Leila B. Giron, Mohamed Abdel‐Mohsen · 2022 · Current HIV/AIDS Reports
35. HIV infected CD4+ T cell clones are more stable than uninfected clones during long-term antiretroviral therapy
    Shuang Guo, Brian T. Luke, Amy R. Henry, Samuel W. Darko, Leah D. Brandt, Ling Su, David F. Sun, Daria Wells, Kevin W. Joseph, Dimiter G. Demirov et al. · 2022 · PLoS Pathogens
36. HIV-PULSE: a long-read sequencing assay for high-throughput near full-length HIV-1 proviral genome characterization
    Laurens Lambrechts, Noah Bonine, Rita Verstraeten, Marion Pardons, Ytse Noppe, Sofie Rutsaert, Filip Van Nieuwerburgh, Wim Van Criekinge, Basiel Cole, Linos Vandekerckhove · 2023 · Nucleic Acids Research
37. HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapy
    Guinevere Q. Lee, Pragya Khadka, Sarah N. Gowanlock et al. · 2024 · Nature Communications
38. Differences in HIV-1 reservoir size, landscape characteristics, and decay dynamics in acute and chronic treated HIV-1 Clade C infection
    Kavidha Reddy, Guinevere Q. Lee, Nicole Reddy, Tatenda JB Chikowore, Kathy J. Baisley, Krista L. Dong, Bruce D. Walker, Xu G. Yu, Mathias D. Lichterfeld, Thumbi Ndung’u · 2024 · eLife
39. New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV
    Mayra A. Carrillo, Anjie Zhen, Jerome A. Zack, Scott G. Kitchen · 2017 · Translational research
40. When do models of NeuroAIDS faithfully imitate “the real thing”?
    Benjamin B. Gelman, Janice Jones Endsley, Dennis L. Kolson · 2017 · Journal of NeuroVirology
41. Sex Differences in HIV Infection: Mystique Versus Machismo
    Eileen P. Scully · 2018 · Pathogens and Immunity
42. Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice
    Matthew M. Hernandez, Audrey Fahrny, Anitha Devi Jayaprakash, Gustavo Gers-Huber, Marsha Dillon-White, Annette Audigé, Lubbertus C. F. Mulder, Ravi Sachidanandam, Roberto F. Speck, Viviana R. Simon · 2019 · Journal of Virology
43. Tat IRES modulator of tat mRNA (TIM-TAM): a conserved RNA structure that controls Tat expression and acts as a switch for HIV productive and latent infection
    Georges Khoury, Charlene Mackenzie, Lilia Ayadi, Sharon R. Lewin, Christiane Branlant, Damian F. J. Purcell · 2019 · Nucleic Acids Research
44. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies
    Maria Carmen Puertas, Ángel Bayón-Gil, Maria C. García-Guerrero, María Salgado, Víctor Urrea, Sara Morón‐López, Ruth Peña, Esther Jiménez‐Moyano, Bonaventura Clotet, Júlia G. Prado et al. · 2021 · mBio
45. Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy
    Jared Stern, Ajantha E. Solomon, Ashanti Dantanarayana, Rachel D. Pascoe, Arnold Reynaldi, Miles P. Davenport, Jeffrey M. Milush, Steven G. Deeks, Wendy Hartogensis, Frederick M. Hecht et al. · 2021 · The Journal of Infectious Diseases
46. A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro
    Kouki Matsuda, Saiful Islam, Toru Takada, Kiyoto Tsuchiya, Benjy J.Y. Tan, Shin-ichiro Hattori, Hiroo Katsuya, Kosaku Kitagawa, Kwang Su Kim, Misaki Matsuo et al. · 2021 · Cell Reports Methods
47. HIV DNA positively correlates with HLA-DR+CD8+ T lymphocytes over 8-year suppressive antiretroviral therapy
    Tianyuan Zhu, Wei Cao, Taisheng Li · 2023 · AIDS
48. The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
    Thibault Mésplède, Jing Leng, Hanh Thi Pham · 2017 · mBio
49. Perspective on potential impact of HIV central nervous system latency on eradication
    Phillip Chan, Jintanat Ananworanich · 2019 · AIDS
50. Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
    Po-Ting Liu, Brandon F. Keele, Peter Abbink, Noe B. Mercado, Jinyan Liu, Esther Apraku Bondzie, Abishek Chandrashekar, Erica N. Borducchi, Joseph Hesselgesser, Michael Mish et al. · 2020 · Nature Communications
51. Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV
    Joshua Rhein, Jeffrey G. Chipman, Gregory J. Beilman et al. · 2025 · JCI Insight
52. Non-Human Primate Models of HIV Brain Infection and Cognitive Disorders
    Sarah J. Byrnes, Thomas A. Angelovich, Kathleen Busman‐Sahay, Catherine R. Cochrane, Michael Roche, Jacob D. Estes, Melissa J. Churchill · 2022 · Viruses
53. Host variation in type I interferon signaling genes (MX1), C–C chemokine receptor type 5 gene, and major histocompatibility complex class I alleles in treated HIV+ noncontrollers predict viral reservoir size
    David Siegel, Cassandra Thanh, Eunice Wan, Rebecca Hoh, Kristen S. Hobbs, Tony Pan, Erica A. Gibson, Deanna L. Kroetz, Peter W. Hunt, Jeffrey Martin et al. · 2022 · AIDS
54. Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill
    Jan Kristoff, Charles R. Rinaldo, Robbie B. Mailliard · 2019 · Viruses
55. The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence
    Antonio Astorga-Gamaza, Maria José Buzón · 2021 · Current Opinion in HIV and AIDS
56. Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR
    Leah D. Brandt, Shuang Guo, Kevin W. Joseph et al. · 2021 · Viruses
57. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection
    Stephen W. Wietgrefe, Lijie Duan, Jodi L. Anderson, Guillermo Marqués, Mark A Sanders, Nathan W. Cummins, Andrew D. Badley, Curtis N. Dobrowolski, Jonathan Karn, Amélie Pagliuzza et al. · 2022 · Journal of Virology
58. Single-cell multiomic understanding of HIV-1 reservoir at epigenetic, transcriptional, and protein levels
    Michelle Wong, Yulong Wei, Ya‐Chi Ho · 2023 · Current Opinion in HIV and AIDS
59. HIV Reservoir: Finding the Right Needles in a Needlestack
    Alexander O. Pasternak, Ben Berkhout · 2016 · Cell Host & Microbe
60. Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
    Rupert E. Capina, Katherine Li, Levon Kearney · 2020 · Viruses
61. Evaluation of HIV-1 Latency Reversal and Antibody-Dependent Viral Clearance by Quantification of Singly Spliced HIV-1 vpu / env mRNA
    Hongbo Gao, Ayşe Naz Ozantürk, Qiankun Wang, Gray H. Harlan, Aaron J. Schmitz, Rachel M. Presti, Kai Deng, Liang Shan · 2021 · Journal of Virology
62. The largest HIV-1-infected T cell clones in children on long-term combination antiretroviral therapy contain solo LTRs
    Johannes C. Botha, Dimiter G. Demirov, Carli Gordijn et al. · 2023 · mBio
63. Specific quantification of inducible HIV-1 reservoir by RT-LAMP
    Tanvir Hossain, Cynthia Lungu, Sten de Schrijver et al. · 2024 · Communications Medicine
64. Footprints of innate immune activity during HIV-1 reservoir cell evolution in early-treated infection
    Weiwei Sun, Ce Gao, Gregory T. Gladkov, Isabelle C. Roseto, Leah Carrere, Elizabeth M. Parsons, Carmen Gasca‐Capote, John Frater, Sarah J. Fidler, Xu G. Yu et al. · 2024 · The Journal of Experimental Medicine
65. Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy
    Milica Moskovljevic, Filippo Dragoni, Nathan L. Board, Fengting Wu, Jun Lai, Hao Zhang, James Robert White, Rebecca Hoh, Kenneth Lynn, Pablo Tebas et al. · 2024 · Immunity
66. Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary
    Yew Ann Leong, Anurag Atnerkar, Di Yu · 2017 · Frontiers in Immunology
67. Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infection
    Nina Orlova-Fink, Fatema Z. Chowdhury, Xiaoming Sun, Sean Harrington, Eric S. Rosenberg, Xu G. Yu, Mathias D. Lichterfeld · 2017 · AIDS
68. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase
    Madison B. Adolph, Anjuman Ara, Linda Chelico · 2019 · Journal of Molecular Biology
69. Potential Utilization of APOBEC3-Mediated Mutagenesis for an HIV-1 Functional Cure
    Terumasa Ikeda, Yue Yuan, Ryo Shimizu, Hesham Nasser · 2021 · Frontiers in Microbiology
70. Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
    Katie Fisher, Timothy E. Schlub, Zoe Boyer, Thomas A. Rasmussen, Ajantha Rhodes, Rebecca Hoh, Frederick M. Hecht, Steven G. Deeks, Sharon R. Lewin, Sarah Palmer · 2023 · Frontiers in Immunology
71. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies
    Nazanin Mohammadzadeh, Tyson B. Follack, Robin P. Love, Kris Stewart, Stephen E. Sanche, Linda Chelico · 2018 · Virology
72. Challenges in Quantifying Cytosine Methylation in the HIV Provirus
    Sarah A. LaMere, Antoine Chaillon, Christina Huynh, Davey Mitchell Smith, Sara Gianella · 2019 · mBio
73. Nonhuman Primate Testing of the Impact of Different Regulatory T Cell Depletion Strategies on Reactivation and Clearance of Latent Simian Immunodeficiency Virus
    Ranjit Sivanandham, Adam J. Kleinman, Paola Sette et al. · 2020 · Journal of Virology
74. Impact of the time to achieve viral control on the dynamics of circulating HIV-1 reservoir in vertically infected children with long-term sustained virological suppression: A longitudinal study
    Matías Moragas, Maximiliano Distefano, Débora Mecikovsky · 2018 · PLoS ONE
75. A Tat/Rev Induced Limiting Dilution Assay to Measure Viral Reservoirs in Non-Human Primate Models of HIV Infection
    Ines Frank, Arpan Acharya, Nanda Kishore Routhu et al. · 2019 · Scientific Reports
76. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption
    Xiaolei Wang, Huanbin Xu · 2021 · Viruses
77. Assessment of intra-sample variability in HIV-1 DNA drug resistance genotyping
    Laurine Millière, Laurence Bocket, Claire Tinez et al. · 2021 · Journal of Antimicrobial Chemotherapy
78. The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
    Sarah E. Benner, Yolanda J. Eby, Xianming Zhu, Reinaldo E. Fernández, Eshan U. Patel, Jessica E. Ruff, Feben Habtehyimer, Haley A. Schmidt, Charles S. Kirby, Sarah Hussain et al. · 2022 · JCI Insight
79. Advances in Pediatric HIV-1 Cure Therapies and Reservoir Assays
    Priya Khetan, Yufeng Liu, Adit Dhummakupt, Deborah Persaud · 2022 · Viruses
80. Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018
    Bashkim Jaha, Corinne D Schenkel, Lisa Jörimann et al. · 2023 · Journal of Antimicrobial Chemotherapy
81. The dual-target approach in viral HIV-1 viremia testing: An added value to virological monitoring?
    Alessandra Amendola, Giuseppe Sberna, Federica Forbici · 2020 · PLoS ONE
82. Amplification of Replication Competent HIV-1 by Adoptive Transfer of Human Cells From Infected Humanized Mice
    Hang Su, Sruthi Sravanam, Santhi Gorantla · 2020 · Frontiers in Cellular and Infection Microbiology
83. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
    Chiara Orlandi, Benedetta Canovari, Federica Maria Bozzano · 2020 · Journal of Translational Medicine
84. Genetically intact but functionally impaired HIV-1 env glycoproteins in the T-cell reservoir
    de Verneuil, Anne, Migraine, Julie, Mammano, Fabrizio, Molina, Jean-Michel, Gallien, Sébastien, Mouquet, Hugo, Hance, Allan J., Clavel, François, Dutrieux, Jacques · 2018 · Journal of Virology
85. The role of tunneling nanotubes during early stages of HIV infection and reactivation: implications in HIV cure
    Silvana Valdebenito, Akira Ono, Li-Bin Rong, E. Eugenin · 2023 · NeuroImmune Pharmacology and Therapeutics
86. A cohort-based study of host gene expression: tumor suppressor and innate immune/inflammatory pathways associated with the HIV reservoir size
    Ashok Kumar Dwivedi, Germán G. Gornalusse, David A. Siegel, Alton S. Barbehenn, Cassandra Thanh, Rebecca Hoh, Kristen S. Hobbs, Tony Pan, Erica A. Gibson, Jeffrey N. Martin et al. · 2023 · PLoS Pathogens
87. The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection
    Andrey I. Murzin, Kirill Artemovich Elfimov, Natalia M. Gashnikova · 2024 · Pathogens
88. Shared Mechanisms Govern HIV Transcriptional Suppression in Circulating CD103 + and Gut CD4 + T Cells
    Steven A. Yukl, Shahzada Khan, Tsui‐Hua Chen, Martin Trapečar, Frank Shao-Ying Wu, Guorui Xie, Sushama Telwatte, Daniel Fulop, Alexander R. Pico, Gregory M. Laird et al. · 2020 · Journal of Virology
89. FRET-Based Detection and Quantification of HIV-1 Virion Maturation
    Anamaria Daniela Sarca, Luca Sardo, Hirofumi Fukuda, Hiroyuki Matsui, Kotaro Shirakawa, Kazuki Horikawa, Akifumi Takaori‐Kondo, Taisuke Izumi · 2021 · Frontiers in Microbiology
90. HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy
    Aniqa Shahid, Bradley R. Jones, J.S.W. Yang, Winnie W. Y. Dong, Tawimas Shaipanich, Kathryn Donohoe, Chanson J. Brumme, Jeffrey B. Joy, Janice M. Leung, Zabrina L. Brumme · 2022 · PLoS Pathogens
91. HIV Reservoir: How to Measure It?
    Xinyu Zhang, Jun Chen · 2023 · Current HIV/AIDS Reports
92. Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays
    Yury V. Kuzmichev, Carol Lackman-Smith, Sonia Bakkour, Ann P. Wiegand, Michael J. Bale, Andrew Musick, Wendy Bernstein, Naomi Aronson, Julie A. Ake, Sodsai Tovanabutra et al. · 2023 · Scientific Reports
93. Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks
    Lisa Jörimann, Jasmin Tschumi, Marius Zeeb, Christine Leemann, Corinne D Schenkel, Kathrin Neumann, Sandra E Chaudron, Maryam Zaheri, Paul Frischknecht, Nadia Neuner-Jehle et al. · 2023 · The Journal of Infectious Diseases
94. Brief Report: Pulmonary Tuberculosis Is Associated With Persistent Systemic Inflammation and Decreased HIV-1 Reservoir Markers in Coinfected Ugandans
    Alex J. Olson, Elizabeth J. Ragan, Lydia Nakiyingi, Nina Lin, Karen Rita Jacobson, Jerrold J. Ellner, Yukari Carol Manabe, Manish Sagar · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
95. On the generation of the MSD-Ѱ class of defective HIV proviruses
    Atze T. Das, Alexander O. Pasternak, Ben Berkhout · 2019 · Retrovirology
96. Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities
    Jason W. Rausch, Stuart F.J. Le Grice · 2019 · Current HIV Research
97. HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design
    Ángel Bayón-Gil, Maria Carmen Puertas, Víctor Urrea · 2020 · Journal of Antimicrobial Chemotherapy
98. Cure and Long-Term Remission Strategies
    Luisa Mori, Susana T. Valente · 2022 · Methods in molecular biology
99. Single-Cell Sequencing Facilitates Elucidation of HIV Immunopathogenesis: A Review of Current Literature
    Silvère D. Zaongo, Vijay Harypursat, Yaokai Chen · 2022 · Frontiers in Immunology
100. Virally Suppressed People Living with HIV Who Use Opioids Have Diminished Latency Reversal
     Binita Basukala, Sarah L. Rossi, Sally Bendiks, Natalia Gnatienko, Gregory J. Patts, Evgeny M. Krupitsky, Dmitry A. Lioznov, Kaku So‐Armah, Manish Sagar, Christine S. Cheng et al. · 2023 · Viruses